THERAVANCE BIOPHARMA INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for THERAVANCE BIOPHARMA INC NOTE 3.250%11/0, CUSIP 88339KAA0.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for THERAVANCE BIOPHARMA INC NOTE 3.250%11/0, CUSIP 88339KAA0.